Bio-Rad Laboratories announces that Louis Drapeau has been appointed to its board of directors and will serve as a member of the board's audit committee
Louis Drapeau replaces Philip Padou who passed away late last year.
Drapeau will stand for election to the board along with Bio-Rad's other directors at the company's annual meeting on April 24, 2007.
Drapeau currently serves as chief financial officer and senior vice president of finance at Nektar Therapeutics.
Previously, he has served in several executive positions including acting chief executive officer as well as senior vice president and chief financial officer at BioMarin Pharmaceutical, and audit partner and managing partner of northern California audit and business consulting at Arthur Andersen.
He currently serves on the board of directors of Inflazyme Pharmaceuticals where he is the chair of the board's audit committee.
Drapeau holds a bachelor of science degree in mechanical engineering and a master of business administration from Stanford University.
